Concepedia

Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy

Betty S. Pio, Cecilia K. Park, Richard J. Pietras, Wei‐Ann Hsueh, Nagichettiar Satyamurthy, Mark D. Pegram, Johannes Czernin, Michael E. Phelps, Daniel Silverman

Molecular Imaging and Biology · 2005 · 221 citations · 19 references

DOI

Concepts

References

19

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography

Anthony F. Shields, John R. Grierson, Bernhard M. Dohmen et al. · Nature Medicine · 1998 · 1.2K citations

, , +12

In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.

Hubert Vesselle, John R. Grierson, Mark Muzi et al. · PubMed · 2002 · 299 citations

, , +17

Early Detection and Accurate Description of Extent of Metastatic Bone Disease in Breast Cancer With Fluoride Ion and Positron Emission Tomography

Holger Schirrmeister, Albrecht Guhlmann, Jörg Kotzerke et al. · Journal of Clinical Oncology · 1999 · 282 citations

, , +17

Practice Guidelines for Tumor Marker Use in the Clinic

Catharine M. Sturgeon · Clinical Chemistry · 2002 · 204 citations · Full text

, , +13

Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.

Joanne Mortimer, Farrokh Dehdashti, Barry A. Siegel et al. · PubMed · 1996 · 200 citations

, , +17